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Summary
Background. -Thrombus straddling the patent foramen ovale (TSFO) is a rare event. It occurs in the presence of pulmonary embolism and can be responsible for paradoxical embolism. The aim of this report is to guide the optimal choice of treatment for TSFO in different clinical contexts.
Methods. -A PubMed search was conducted of articles published between 1985, when the first TSFO was reported, and 2007. We identified 93 cases of TSFO diagnosed by echocardiography, nine of which were excluded because of lack of information. We analysed data from these 84 patients plus a further four seen at three French cardiology departments.
Results. -The patients' mean age was 58 years. Pulmonary embolism was present in 94% of cases, and was severe in 34%. Paradoxical embolism, before or after treatment, was found in 44% of cases.
Fifty-five patients were treated surgically, 21 were treated with heparin, and 11 received thrombolysis. The mortality rates for the treatments were 13, 14 and 36%, respectively. Patients who received heparin were older (60 ± 17 years) and had more strokes (11/21) than the surgical group (56 ± 15 years, 14/55). The group that received thrombolysis was more likely to have haemodynamic compromise. Conclusion. -Medical treatment with heparin tends to be used as a second option in patients with more frequent comorbidities and strokes but the mortality rate is similar to that in the surgical group. Surgery seems to be justified in the prevention of paradoxical embolism. Thrombolysis is more frequently chosen in the higher risk group and is associated with the greatest mortality. © 2008 Elsevier Masson SAS. All rights reserved. 
MOTS CLÉS

Background
Reports of thrombus straddling the patent foramen ovale (TSFO) are rare. In the presence of systemic embolism, the diagnosis of paradoxical embolism is certain when TSFO is found. In 1985, Nellessen et al. [1] reported the first clinical case diagnosed by echocardiography. Despite the advent of this technique, TSFO is still rarely diagnosed and its therapeutic management remains unclear. Therapeutic options include surgical treatment with thrombectomy or medical treatment with heparin or thrombolysis.
We report four cases of TSFO diagnosed by echocardiography in three French cardiology departments: two were treated with surgery and two with anticoagulation. In addition, through a PubMed search, we identified 93 published cases of TSFO, nine of which were excluded as they did not include precise data. We analysed the clinical presentations, paraclinical examinations, treatments and outcomes of these 88 cases.
Case 1
An obese (body mass index 40 kg/m 2 ) 50-year-old woman complained of dyspnoea with desaturation (88% in ambient air) and collapsus, 3 days after knee ligamentoplasty. Lower limb venous echo-Doppler described bilateral venous thrombosis. Spiral computed pulmonary tomography found proximal bilateral pulmonary embolism (PE). The patient initially received intravenous thrombolysis associated with unfractionated heparin treatment. Transthoracic echocardiography (TTE) conducted the following day revealed a mobile thrombus 4 cm long entrapped in a patent foramen ovale (PFO) (Fig. 1) , which prolapsed into the right ventricle. The right cavities were dilated. She was transferred, as an emergency, to a cardiac surgical centre for thrombectomy associated with closure of the PFO and pulmonary embolectomy (Fig. 2) . Abdominal and cerebral scanning did not find any paradoxical embolism. The patient is doing well 2 years later, on prolonged anticoagulation treatment. 
Case 2
An 86-year-old man was hospitalized for chest pain combined with lipothymia and dyspnoea, a few days after hospitalization for urinary septicaemia. Clinical examination found a blood pulse of 120/min, normal arterial blood pressure (120/70 mmHg) and signs of clinical right heart failure. Lung scintigraphy concluded that there was a high probability of PE. TTE described dilated right cavities, paradoxal septum, arterial pulmonary hypertension of 70 mmHg and a serpentine and mobile thrombus in the left atrium. Transoesophageal echocardiography (TEE) showed a thrombus entrapped in the PFO (Fig. 3) . Lower limb venous echoDoppler described bilateral venous thrombosis. A cerebral scan was normal. Treatment with hypocoagulant unfractionated heparin was started, relayed by oral anticoagulation. TEE, conducted after 7 days of treatment, showed persistent thrombus entrapped in the PFO but reduced in size and with a decreased arterial pulmonary pressure of 40 mmHg. After 15 days, the thrombus had disappeared. The patient's long-term outcome was favourable at 3 years.
Case 3
A 73-year-old man was hospitalized for syncopa and dyspnoea. His medical history included cardiac surgery with coronary bypass and mitral annuloplasty after myocardial infarct, pulmonary tuberculosis, hypertension and dyslip- idaemia. Clinical examination found a blood pressure of 100/70 mmHg, a pulse rate of 96/min and moderate clinical signs of right heart failure. A pulmonary CT scan described bilateral PE associated with mural thrombosis of the descending aorta. TTE showed pulmonary hypertension of 46 mmHg and right ventricle enlargement. TEE was done to explore aorta thrombosis and revealed a thrombus long of 2.6 cm, trapped in the PFO. The descending aorta was dilated without signs of dissection. Lower limb venous echoDoppler showed a right femoral thrombosis. Anticoagulant treatment was started. TTE control after 7 days revealed no remaining atrial thrombus. Abdominal and cerebral CT scan showed no paradoxical embolism. TEE performed after 9 days of anticoagulant treatment confirmed that the TSFO had disappeared, and showed a PFO with colour Doppler. The patient was discharged on oral anticoagulation and remained symptom free over 1 year of follow-up.
Case 4
A 74-year-old man was admitted for an acute ischaemic left leg and dyspnoea. Emergent echo-Doppler visualized complete thrombotic occlusion of the femoral artery associated with femoral venous thrombosis. The leg was amputated because of severe left leg ischaemia. TTE, performed a few days after the intervention because he remained dyspnoeic, demonstrated a TSFO that had prolapsed through the tricuspid valve into the right ventricle, which was dilated and hypokinetic. CT scan pulmonary angiography showed bilateral proximal PE. Emergency thromboembolectomy under cardiopulmonary bypass was performed. A 16 cm long thrombus, which crossed the interatrial septum, was removed and the PFO closed by direct suture. The patient had an uncomplicated postoperative course, but a long readaptation was necessary because of the left leg amputation.
Methods
A PubMed search of the literature published between 1985 and 2007 was conducted using the search terms 'paradoxical embolism' OR 'impending paradoxical embolism' OR 'thrombus straddling patent foramen ovale' without language restriction. We also searched the reference lists of retrieved articles to identify any additional studies. We selected only cases of TSFO diagnosed by echocardiography before surgery and with thrombus entrapped in the PFO clearly visualized. Two literature reviews on TSFO were published in 1998 by Meacham et al. [2] and Aboyans et al. [3] , which reported 30 and 43 cases, respectively. In 2003, Chow et al. [4] published a review of impending paradoxical embolism but included cases of TSFO diagnosed during surgery or postmortem, which were excluded from our review. We found a total of 93 cases of TSFO .
We reviewed the available data concerning the clinical characteristics, paraclinical examinations, treatments and outcomes for all cases. Most were published in case-report format, but the descriptions were not always very specific. Some cases were reported only in letters or as images. Nine were included in reviews of impending paradoxical embolism or intracardiac thrombus, and failed to include any details concerning TSFO, or the data were in languages that we were unable to translate, and were therefore excluded from our review [8, 11, 28, 33, 34] . The study population therefore comprised 88 cases of TSFO, 84 from the literature and four seen at our institutions.
Results
The clinical characteristics are summarized in Table 1 . The clinical presentations were non-specific. TSFO was diagnosed in the context of thromboembolic disease or systemic embolism. We found risk factors for venous thromboembolism in 47 patients, including recent surgery, hospitalization, progressive cancer, coagulation disturbance or systemic disease (e.g., lupus, antiphospholipid syndrome, protein S deficiency) and other medical conditions such as dehydration, obesity, renal polycystosis, immobilization and an association between oral contraception and tobacco. The most frequently reported symptoms were, in descending order, dyspnoea, tachycardia, chest pain, hypotension, syncope or lipothymia, shock, hepatojugular reflux or venous jugular turgescence, cyanosis, auricular fibrillation and haemoptysis. Clinical signs of severe pulmonary embolism, including syncope, collapsus, shock and cardiac arrest, were present in 30 patients. Seventeen patients had cardiogenic shock or cardiac arrest. Almost half of the patients presented with an association between PE and systemic embolism (36/88 patients) before treatment. Two cases of paradoxical embolism occurred after treatment [4, 35] . The most frequent site of systemic embolism was cerebral, including four transient ischaemic attacks and 22 ischaemic strokes. Other sites of systemic embolism were the inferior or superior limbs, kidneys, coronary arteries and spleen. Eight patients had multiple emboli in different areas.
The types of paraclinical examinations performed to confirm the presence of PE were detailed in 50 patients, with lung perfusion/ventilation scintigraphy in 34 cases (until 1996) and lung spiral CT in 16 patients. Venous thrombosis was documented in 47 patients by venous echo-Doppler.
All patients underwent echocardiographic diagnosis of the thrombus entrapped in the PFO. For 26 patients the TSFO was clearly visible on TTE, but for the majority of patients it was visible only by TEE (56 patients). These TEE were performed after TTE in order to diagnose accurately the intracardiac thrombus visualized by TTE for the majority of individuals (28 cases). More frequently, the clot was seen on TTE in the right atrium (24 cases), but sometimes associated with other locations such as the left atrium (four cases), inferior vena cava, right ventricle (two cases) or in the four chambers of the heart. For two patients, TEE was performed after identification of a left atrial thrombus, without any thrombus identified in the right chambers by TTE. Others cases of TSFO diagnosis on TEE were:
• diagnosis of paradoxical embolism after systemic embolism in eight patients; • TEE in ventilated patients performed for severe PE who could not undergo TTE; • clinical worsening in the context of PE in two cases;
• suspicion of aortic dissection in two cases. For 14 patients, the indication of TEE was not detailed. In most cases, the thrombus was described as long, extremely mobile, snake-like or serpentine and often prolapsing into the right and left ventricle through the tricuspid or mitral valves. Sometimes it was visualized in the inferior vena cava or prolapsing through the aortic valve.
The right ventricle was described in 35 cases, always dilated. Pulmonary pressure was detailed for 28 patients, and was on average 60 ± 14 mmHg (range 40-100). Information on the type of treatment chosen was available for 88 patients ( Table 2 ). All patients were anticoagulated except for one who was treated with an isolated inferior vena cava filter because of a recent cerebral haemorrhage [35] . Twenty-one patients were treated with anticoagulants alone (heparin relayed by a vitamin K antagonist). Thrombolysis was administered in 13 (18%) patients, two of whom subsequently underwent surgical treatment (Fig. 4) . The first patient was operated on because of failure of thrombolysis [7] ; the second patient was Case 1 (detailed earlier). Two patients [4, 36] received thrombolytic treatment despite a diagnosis of paradoxical embolism, including one stroke. Fifty-five patients finally underwent emergency surgery; in 44 of these cases the type of surgery was detailed. Surgery was associated with cardiac thrombectomy on extracorporeal circulation with closure of the PFO. In 17 of 44 cases Total immediate mortality, n (%)
14 (16) 7 (13) 3 (14) 4 ( pulmonary thrombectomy was performed and in one case, pulmonary thrombo-aspiration was performed. The size of the thrombus was reported in 31 cases: it measured on average 13 ± 7.5 cm. The longest thrombus measured 41 cm [7] . Clinical outcomes according to type of treatment are reported in Table 2 . Patients treated with heparin and thrombolysis were older (60 ± 17 years and 61 ± 9 years, respectively) than those treated with surgery (56 ± 15 years). The group treated with heparin had more frequent stroke. Among the 30 patients with severe PE for whom treatment data were reported, the proportion of heparin and thrombolysis treatments was reversed (Fig. 5) .
Most authors chose surgical treatment as the first option. Ten authors explained why they choose anticoagulant treatment; they preferred this treatment because of important associated comorbidities including advanced age, progressive cancer, stroke and haemodynamic instability. One author [37] choose this treatment as the first option, arguing that the embolic risk was weak based on the echographic aspect of the thrombus, which was described as small and immobile. One author selected this treatment in a young patient without comorbidities [31] , and chose to reserve surgery or thrombolysis as the second option. The TSFO of this patient measured 4 cm on TEE. Our two cases, treated by heparin only, presented small TSFO and had favourable outcomes. Authors' arguments for using thrombolysis were the presence of unstable haemodynamics and comorbidities. Two patients [4, 38] had a paradoxical embolism after diagnosis of TSFO. The first received systemic urokinase associated with a bolus of 1,000,000 IU injected into the right cardiac cavities through a Swan-Ganz probe. The patient presented sudden ischaemia of the right upper limb. The second patient presented an arterial embolism of the left lower limb, whereas he was treated with heparin in an attempt at surgical embolectomy. He was then treated with thrombolysis. One patient presented a cerebral haemorrhage [18] after thrombolytic treatment.
Thrombus-monitoring echocardiography was specified for 11 of the 21 patients treated with heparin. TSFO disappeared after a mean of 12 days (range 4 days to 6 weeks) without clinical embolic events. After thrombolysis in the survivor population, the thrombus disappeared within 4 h to 6 days.
Total mortality was 16% (14/88), 7/55 in the surgical group, 3/21 in heparin-treated patients and 4/11 in patients who received thrombolysis. For patients who presented with severe PE (shock, cardiac arrest, collapse and syncope), total mortality was higher (13/30) and was similar regardless of treatment choice with 7/17, 2/4 and 4/8 deaths in the surgical, heparin and thrombolytic treatment groups, respectively, and survival of the patient treated by isolated vena cava filter (Table 2) .
Discussion
This review of all published cases of TSFO provides insights into the clinical context of TSFO occurrence.
We report, along with four new cases, the largest series of TSFO ever published. The first TSFO diagnosed by echocardiography was reported in 1985; the authors believed that progress involving echocardiography would make TSFO a frequent diagnosis but it remains uncommon.
Our review confirms the association between TSFO and thromboembolic disease, and frequently with severe PE, as describe with right-sided heart thrombus [39] . Severe PE, with increased pulmonary and right ventricle pressures, could support clot migration across the PFO, by interauricular pressure gradient reversal.
The frequent association of TSFO with paradoxical embolism is also interesting, and in particular the frequent cerebral site of embolism. It encourages most authors to start aggressive treatment to prevent cerebral embolism.
Echocardiography is essential for diagnosing TSFO because it has been the only way, until now, to diagnose this condition. We must highlight the essential role of TEE. Often TSFO is not visualized by TTE, which means that TEE must be performed as an emergency, when intracardiac mass is diagnosed or severe PE or thromboembolic disease associated with systemic embolism with the suspicion of paradoxical embolism. Indeed, the description of TSFO could change the therapeutic approach.
The original finding from our study is the frequent use of medical treatment with heparin and the favourable outcome in this group of patients. Theoretically thrombolysis or anticoagulation appears hazardous and the risk of paradoxical embolism encourages most authors to be more aggressive in their treatment strategy. However, in this review there is only a slight difference in the mortality rates after heparin or surgical treatment. Patients treated by thrombolysis have a higher mortality but they have greater hemodynamic compromise, which explains this mortality difference. Indeed, if we compare patients with severe PE, mortality is similar, independent of treatment used. It appears that mortality is linked more to the severity of clinical presentation than to the type of treatment. The risk of paradoxical embolism is very difficult to predict. In this review paradoxical embolism after TSFO diagnosis was reported in only two patients. It seems that whereas the risk of systemic embolism is important before treatment, it is decreased with anticoagulant treatment. In echocardiography monitoring the thrombus was still present after several days, and even after it had disappeared it tended to not to be associated with clinical embolism. The risk of thrombolysis to fragment the clot and induce paradoxical embolism is often cited by authors. The size of the TSFO seems to be another important point for embolic risk.
Based on this review, anticoagulant treatment appears to be an acceptable therapeutic alternative to surgery, particularly in patients with comorbidities (e.g., increased age, stroke, progressive cancer) who are at high surgical risk, and for patients with small TSFO. It is difficult, however, to provide recommendations for the management of patients presenting with TSFO because of the methodological limitations of our study. The data are based on a compilation of individual published cases, and are therefore subject to important bias. The heterogeneity and the probability of unpublished cases are responsible for the lack of information. Another limitation concerns patients who received multiple treatments. We took into account the last treatment patients received. Because of these methodological limitations, we did not make any statistical comparisons between the groups. However, we used this approach because of the paucity of published reports on TSFO.
Conclusions
TSFO is a complication of severe thromboembolic disease, with the migration of thrombus in left-heart cavities in favour of pulmonary hypertension. It is frequently responsible for paradoxical embolism before it has been diagnosed. Diagnosis is easy using echocardiography but it is often necessary to complete TTE with TEE to show it clearly. TEE is justified in the case of intracardiac mass, severe PE and suspicion of paradoxical embolism.
Thrombectomy under extracorporeal circulation is the most frequently chosen treatment in the published literature. Patients treated with heparin were older and more likely to have had a stroke or to have comorbidities than operated patients. Thrombolysis is reserved for patients with severe PE and an unstable status, who cannot wait for surgery.
There was a very slight difference in mortality between patients treated with heparin and the surgical group. However, surgical treatment appears justified in the prevention of paradoxical embolism, and must be done without delay if it is the preferred treatment strategy. Heparin appears to be an acceptable alternative. Thrombolysis is linked to the highest mortality, which could be explained by the severity of the patient's initial presentation.
